BPA Call FA239622A0003-FA239623F0009
Award Date
10/14/22
Potential Completion Date
10/18/22
Potential Value
$16K
Funding Federal Agency
AFLCMC Wright Patterson AFB
Contracting Federal Agency
Air Force
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
WRIGHT PATTER, OH 45433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Air Force Materiel Command awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic substances, reagents, test kits, and sets. The $125,331.41 firm fixed-price contract, awarded on October 1, 2017, is for the provision of these clinical diagnostic products and services to support infectious disease testing and analysis. Biomerieux Inc. is an experienced federal contractor, holding multiple active...
This $133,780.66 firm-fixed price contract was awarded by the Department of the Air Force Defense Finance and Accounting Service to Biomerieux Inc. for in vitro diagnostic substances, reagents, test kits, and sets. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics that provides microbiological testing solutions for medical and industrial applications to determine the source of disease and contamination. The contract leverages...
This federal contract was awarded by the Department of the Air Force Air Education and Training Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of microbiology reagents and supplies. The $103,729.72 firm fixed-price delivery order has a completion date of September 30, 2019. Biomerieux Inc. is a global leader in in vitro diagnostics, offering solutions for medical and industrial microbiology applications. The company has an active Indefinite...
This firm-fixed-price Blanket Purchase Agreement (BPA) call was awarded by the Bureau of Medicine and Surgery, a Defense agency, to Biomerieux Inc. through its Biomerieux, Inc. Division. The contract, valued at $125,000.00, is for the delivery of reagents with a period of performance ending on September 30, 2015. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing solutions for medical, food safety, and industrial applications. The company provides...
This firm-fixed-price purchase order awarded to Biomerieux Inc. is for the supply of TEST KIT,BACTERIA D (8510901429) to the Defense agency's Medical Supply Chain. The $1,757.82 contract has an ultimate completion date of October 7, 2024. Biomerieux Inc., a global leader in in vitro diagnostics, is providing this product through its Biomerieux, Inc. division. This award is not set aside and is likely a direct purchase, as Biomerieux's specialized diagnostic platforms are often sole-source...
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
This firm-fixed-price delivery order was awarded by a U.S. government agency to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of its proprietary BioMerieux products. The $56,200 contract is for BioMerieux's specialized clinical diagnostic equipment, reagents, and supplies, including automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. The award was made under Biomerieux's Federal Supply...
The U.S. Defense Health Agency (DHA) awarded a $164,607.03 firm-fixed-price purchase order contract to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and equipment. The contract is for the provision of reagents and supplies, with a completion date of September 30, 2023. Biomerieux Inc. is a leader in microbiology testing solutions for medical and industrial applications, providing products and services that support infectious disease testing and food...
Biomerieux Inc., through its Biomerieux, Inc. Division, has been awarded a Blanket Purchase Agreement (BPA) call contract by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The $69,870.49 firm-fixed-price contract is for the provision of BioFire panel reagents under the Invitro Diagnostics, Reagents, Test Federal Supply Schedule contract. This contract does not have a set-aside designation. The contract has an ultimate completion date of July...
This $15,970.24 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc. for BioFire Mycoplasma test kits. The contract has an ultimate completion date of September 30, 2024 and does not have a set-aside designation. Biomerieux Inc., a global in vitro diagnostics leader, provides a range of clinical diagnostic equipment, reagents, and supplies to federal agencies through various Indefinite Delivery Vehicles (IDVs), including...